NIH Funding Reprioritized

The White House uses its new control over NIH grants to shift a visible share of new awards toward women’s health topics. The move benefits diagnostics, reproductive health, oncology, and maternal-health research, while creating uncertainty for universities and biotech programs outside the favored categories.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.